AGN-229666 ophthalmic solution

· Allergan

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AGN-229666 ophthalmic solution, covering 2015-10-08 to 2015-10-08. Get the full timeline:

Most recent: Clinical Trial Update: AGN-229666 Ophthalmic Solution for the Treatment of Seasonal or Perennial Allergic Conjunctivitis [Phase 3]